Skip to main content
Innovotech Inc. logo

Innovotech Inc. — Investor Relations & Filings

Ticker · IOT ISIN · CA45772U1049 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 165 across all filing types
Latest filing 2025-08-20 Interim / Quarterly Rep…
Country CA Canada
Listing TSXV IOT

About Innovotech Inc.

https://innovotech.ca/

Innovotech Inc. is a specialist in antimicrobial and biofilm solutions, recognized as a pioneer in biofilm product development and contract research. The company focuses on providing innovative and practical solutions to medical, agricultural, and industrial problems caused by microbial biofilms. Key offerings include specialized assay kits used globally for growing microbial biofilms in research applications. Through Innovotech Labs, the company provides comprehensive, accredited (GMP and ISO) contract testing services, including analytical, microbiological, and antimicrobial testing. These services target the pharmaceutical, biotechnology, medical device, and nutraceutical industries, aiming to ensure regulatory compliance and product optimization.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Consolidated Financial Statements' for Innovotech Inc. for the three and six-month periods ended June 30, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Changes in Shareholder's Deficiency, Statement of Operations and Comprehensive Income, and Statement of Cash Flows) along with detailed notes to the financial statements. It is not an announcement or a certification, but the actual interim financial report itself. H1 2025
2025-08-20 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a News Release dated August 19, 2025, titled “Innovotech Inc. Reports Results For Its Second Quarter And Half-Year Ended 30 June 2025.” It provides key quarterly and half-year financial metrics (revenues, loss, one-time expense) and management commentary, characteristic of an earnings release. It is not a full interim report, but an initial summary announcement of period results, fitting the Earnings Release category. H1 2025
2025-08-20 English
News release - English.pdf
Director's Dealing Classification · 1% confidence The document is a news release announcing the grant of stock options to the company’s seven directors as part of their remuneration. This constitutes a report of insider transactions by directors (option grants) rather than a full annual or interim report, dividend notice, or other category. Therefore, it falls under Director’s Dealing (insider share transactions).
2025-07-10 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a news release announcing the outcome of the company’s Annual General and Special Meeting, detailing the results of shareholder votes (re‐election of directors, appointment of auditors, continuation of a compensation plan) and announcing board changes. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-07-09 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a news release detailing Innovotech Inc.’s receipt of US$402,926 from the sale of its position in a private company. It describes a financing transaction (asset disposal) that impacts the company’s capital. This fits the definition of a Capital/Financing Update (CAP). It is not an earnings release, proxy, or report announcement, and it specifically focuses on a financing event rather than regulatory or other categories.
2025-07-09 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the Notice of Annual General and Special Meeting of Shareholders together with a detailed Management Information Circular. It includes proxy solicitation instructions, meeting agenda items, director election, auditor appointment, compensation plans, corporate governance details, schedules, and forward‐looking statements typically found in a proxy statement. This matches the Proxy Solicitation & Information Statement category (PSI).
2025-06-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.